OKYO Pharma Limited (“OKYO” or the “Company”) – Grant of options – Director and PDMR dealings
LONDON, Feb. 01, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a…
LONDON, Feb. 01, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a…
NANTES, France, Feb. 01, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)…
Paris-based Amelia commits to purchase three Universal Hydrogen conversion kits as the airline seeks to…
SAN JOSE, Calif. & BRACKNELL, England & TOKYO–(BUSINESS WIRE)–#cloudtechnology–Contact centre and customer experience technology leader,…
New Contentsquare report uncovers the critical need for brands to understand digital bottlenecks that negatively…
Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam…
PARIS & LONDON–(BUSINESS WIRE)–#innovation–Covéa, a French mutual insurance group bringing together the MAAF, MMA and…
AI-powered software for Rally Bar and Rally Bar Mini uses a unique dual-camera system to…
Payments service provider COMO Global to utilize ACI Secure eCommerce, giving merchants access to wide…
MATRIXX partners with Google Cloud to maximize customer privacy in a public cloud environment without…
The innovative European company serves more than 7,000 partners with leading-edge solutions enabling security, agility…
Company’s analysis of independent survey reveals barriers to new enterprise service launches Results show nearly…
Company’s New AI-Based Product Helps Organizations Identify Tasks at Scale to Automate or Streamline using…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Feb….
Calgary, Alberta–(Newsfile Corp. – January 31, 2022) – Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the…
DURHAM, N.C.–(BUSINESS WIRE)–Wolfspeed, Inc. (NYSE: WOLF) (“Wolfspeed”) today announced the pricing of $650.0 million aggregate…
CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a…
JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage…
CEPI-funded trial intended to support potential label expansion in this age group Saint–Herblain (France), January…
Oxford Biomedica announces that Sio Gene Therapies intends to cease the license agreement for gene…